Skip to main content
Caplight Logo









Psychodemia

Psychodemia

Private
MoscowHealthcare & Life Scienceshttps://psychodemia.ru/

Last Round

Growth Equity

Oct 4, 2022

Company Overview

Psychodemia is an education and training services company that operates an online school providing courses in psychological counseling, coaching, sexology, and human resources.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, HR

Business Model

B2C

Customer Profile

Services & Consulting, Freemium

AI Layer

Application

Keywords

psychologist trainingonline educationEdTechprofessional retrainingcontinuing educationmental health educationonline master's degreecorporate trainingCBT trainingcoaching certificationemployee well-beingsoft skills trainingHR trainingAI in mental health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Psychodemia Comparables

Compare Psychodemia with similar companies based on industry and business-model similarity.

Psychodemia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Talentsy
88%
5 Prism Academy
86%
Sreda Obucheniya
79%

Psychodemia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 4, 2022
Growth EquityFeb 16, 2022

Key People

Founding team and executive leadership

Alexandra Karavaeva

Chief Operating Officer

Executive Team

Psychodemia Investors

Notable investors and investment history

Psychodemia investors
InvestorRounds
Ultimate EducationGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2024

    Grew 29% QoQ, from 21 to 27 employees.

  • Apr 24, 2024

    Grew 20% QoQ, from 20 to 24 employees.

Psychodemia Filings

Explore SEC and related filing metadata, where available.

Psychodemia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Psychodemia's valuation, stock price, and market status.

Is Psychodemia a public or private company?

Psychodemia is a private company.

What is the current stock price of Psychodemia?

Psychodemia is a private company with no public stock price. No recent secondary market data is available.

How much is Psychodemia worth (valuation)?

Valuation information for Psychodemia is not publicly available.

Can I buy Psychodemia stock?

Psychodemia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Psychodemia's last funding round?

Funding round information for Psychodemia is not publicly available.

Who are the main investors in Psychodemia?

Investor information for Psychodemia is not publicly disclosed.

Will Psychodemia IPO soon?

No public IPO plans have been announced for Psychodemia.

How can I track Psychodemia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Psychodemia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMoscow
Employee Range30
Year Founded2016
Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?